100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
Key-Drugs-Mnemonics-Study-Tips-Pebc-Osce-Resources.pdf £5.54   Add to cart
Quickly navigate to
Preview
  2.  
  3. Cyber Security
  4.  
  5. Cyber security

Judgments

Key-Drugs-Mnemonics-Study-Tips-Pebc-Osce-Resources.pdf
 0 view  0 purchase
  • Module
  • Cyber security
  • Institution
  • Cyber Security

Key-Drugs-Mnemonics-Study-Tips-Pebc-Osce-R

Preview 3 out of 18  pages

Document information

  • March 11, 2024
  • 18
  • 2023/2024
  • Judgments
  • Unknown

Subjects

  • key drugs mnemonics study tips pebc osce resources

Written for

  • Cyber security
All documents for this subject (233)

Seller

avatar-seller
Studyabroad

Content preview

RXPREP:
KEYDRUGS,
MNEMONI
CS,
STUDY CYPi nhibitors
o G<3PACMAN( bi gi nhi bitors)
TI
PS  Gr apef rui t
 HAZARDOUSDRUGSar e:  PI spr ot easei nhi bitor s(ritonav ir
)
o Ter at ogeni c  Azol eant i
f ungal s( fluconazol e,
o Car ci nogeni c itraconazol e, ket oconazol e,
o Genot oxi c( damaget heDNAandcancause posaconazol e, vor i
conazol e,
cancer ) isav uconazoni um)
o Hav er epr oduct i
v et oxi ci ty  C: CYA, cimet idine, cobi cist at
o Causeor gant oxi cityatl owdoses  Macr ol i
des( clarithromy cin,
 Keyhazardousdr ugst hatr equi reSPECI AL er y thromy cin, notazi thromy cin)
HANDLINGt oav oidt oxi ci t
yt owor ker s:  Ami odar one( anddr onedar one)
o Al l pregnancycat egor yXdr ugs, cat egor yD’ s  Non- DHPCCBs( dilti
azem and
andaf ewC’ s, andpar oxet ine, met hotrexat e, v er apami l
)
mi sopr ost ol, mi fepr istone, r i
bav ir
in  KeySEROTONERGI Cdr ugs:
o Ant ineopl ast ics( chemot her apeut i
cs) o SSRI s
o 5- alphar educt asei nhi bi tor s( dut asteride, o SNRI s
fi
nast er ide) o TCAs
o Hor mones( cont racept iv es, estr adiol, o MAOI s( plusl i
nezol idandmet hy l
enebl ue)
test ost er one) o Buspi rone
o Tr anspl antdr ugs( MMF, tacr oli
mus, CYA, o Dext romet hor phan
ever ol imus, sir olimus) o Fent any l
o Ot her s: col chi ci ne, dr onedar one, fl
uconazol e, o Li thium
spir onol act one, ri
sper idone, raloxi fene, o Met hadone
rasagi li
ne, zi pr asidone o Mi rtazapi ne
 Keydrugsmostcommonl yassoci at edwi t
h o St .John’ sWor t
PHOTOSENSI TI VITY: o Tr amadol
o Car bamazepi ne o Tr azodone
o Di ur et i
cs( thiazi deandl oop) o Ot her s:cy clobenzapr ine, lorcaser i
n,
o MTX meper i
di ne, 5HT3- RA, somet riptans
o Or al andt opi cal retinoi ds  Keydr ugsr equi red/ strongl yr ecommendedPGx
o Qui nol ones test
ing:
o St .John’ sWor t o Abacav ir
o Sul faant i
bi ot ics o Azat hiopr ine
o Tacr olimus o Car bamazepi ne
o Vor iconazol e o Cet uxi mabandpani tumumab
o Ot her s: ami odar one, ant ihi stami nes( 1st o Tr ast uzumab, ado- transt uzumab, lapat ini
b,
gener at i
on) , chl or oqui ne, coal tar, pertuzumab
fl
uor our aci l, gr i
seof ulv i
n, NSAI Ds, quini dine, o Ot her s:al lopur inol ,capeci tabi ne, f
luor ouraci
l,
ti
gecy cline cl
opi dogr el, codei ne, pheny toi n, f
ospheny toi
n,
 Keydrugscommonl yassoci atedwi thTTP: warfar in
o Cl opi dogr el  Keydr ugs-DONOTputt hesedr ugsi ntoPVCI V
o Ti clopi dine CONTAI NERS
o Ot her s: acy clov i
r ,famci cl ov ir,qui nine, SMX, o LATI N
valacy clov ir  Lor azepam
 CYPinducer s  Ami odar one
o PSPORCS( bigi nducer s)  Tacr olimus
 Pheny t
oi n  I nsul in
 Smoki ng  NTG
 Phenobar bital  Ot her s: cabazi taxel ,car must i
ne,
 Oxcar bazepi ne( and docet axel , etoposi de, ixabepi lone,
esl icar bazepi ne) pacl itaxel ,suf entani l
, temsi r olimus,
 Ri fampi n( andr ifabut i
n, rifapent ine) teni posi de, t
hi opent al
 Car bamazepi ne( al soanaut o- 
inducer )
 St .John’ sWor t





1

, Keydr
ugs-SALINE( nodext rose) Keydrugs-TERATOGENS
o ACI DAPE o Acne: isot ret i
noi n, topi cal retinoi ds( i
ncluding
 Ampi cill
in tazar otene)
 Caspof ungi n o Abx: qui nol ones, tetracy clines
 I nf liximab o Ant icoagul ant s: war farin
 Dapt omy ci n o HLD, HF, HTN: st atins, RAASi nhi bitors( ACEi
,
 Ampi cill
in/ sul bact am ARBs, al i
ski ren, sacubi tril
/ val
sar t
an)
 Pheny toin o Hor mones: most ,incl udingest radiol,
 Er tapenem pr ogest er one[ megest erol (Megace) ]
,
 Ot her s: abat acept ,azaci tidine, raloxi fene, Duav ee, test ost erone,
bel i
mumab, bev aci zumab, cont racept ives
i
dar uci zumab, ironsucr ose, sodi um o Mi gr aine: dihy droer got ami ne, ergotami ne
ferricgl uconat ecompl ex , o Ot heri mpor tantt er atogens: hy droxy urea,
nat alizumab, t
rast uzumab l
ithi um, MTX, mi sopr ost ol,par oxet i
ne,
 Keydr
ugs-DEXTROSE( nosal ine) ribav irin, thal idomi de, topi ramat e,VPA,
o ABS div alproex, wei ghtl ossdr ugs
 Amphot er icinB  Avoi
di nPEDI ATRI CS
 Bact rim o Cont raindi cat ed
 Sy ner ci d( qui nupr istin/dal fopr isti
n)  Codei neage<12y
 Ot her s: car f i
lzomi b,MMF,  Tr amadol age<12y
pent ami di ne  Pr omet hazi neage<2y
 Keydr
ugs-commondr ugswi t
hFI LTERr equi rement s  Cef tr iaxonei nneonat es1- 28d
o Most :0.22- mi cr onf il
terdur ing o Notgener allyr ecommended
administr
at ion*  Qui nol ones
o Pushyguy sinLALAl and  Tet racy clinesage<8y
 Pheny toin  OTCcoughandcol dpr epar ationsin
 Gol imumab age<6y
 Li pids-1. 2mi cr on*  Li
vev accines
 Amphot er icinB( l
ipidf or mul ations) * o I nject ions
 Lor azepam  MMR
 Ami odar one  MMRV
 *l argerpor esi zef il
ter  Var icel la
r equi red; amphopr epar e  Zost er
usi nga5- mi cronf ilter  Yel lowf ev er
 Ot her s: abat acept ,abci ximab, o Ot herr out es
digoxi ni mmunef ab, infliximab,  I nf l
uenzai nt ranasal
i
sav uconazoni um, manni tol,  Rot av ir
us
thiot epa  Chol er a
 Keydr
ugs-DONOTREFRI GERATE  Ty phoi d
o Dearsweetphar maci st, mar rymef or ev er,  Vacci
nesf orspeci f i
ccondi tions
eter
nally o Pr egnancy
 Dexmedet omi dine  I nf l
uenzav acci ne
 SMX- TMP  Tdapx1wi t heachpr egnancy
 Pheny toin (opt imal timebet weenweeks27
 Met roni dazol e and36)
 Moxi floxaci n  Li v ev acci nesCIdur ingpr egnancy
 Fur osemi de o Aspl eni a
 Enoxapar in  H.i nf luenzaet ypeB( HI B)
 Ot her s: acet ami nophen, acycl ov i
r,  Pneumococcal (Prev narand
def er oxami ne( Desf eral) , Pneumov ax23)
l
ev et iracet am, pent ami di ne,  Meni ngococcal
valpr oat e  Sel
ecteddr ugst hatCAUSEKI DNEYDI SEASE
 Keydr
ugs-PROTECTFROM LI GHTDURI NG o Ami nogl ycosi des
ADMINI
STRATION o Amphot er icinB
o Del i
verev eryneededmedi cationpr ot ect ed o Ci splat in
 Doxy cy cline o Col ist i
met hat e
 Epopr ost enol o CYA
 Ni t
r opr ussi de o Loopdi uret ics
 Mi caf ungi n o NSAI Ds
 Phy tonadi one o Radi ogr aphi ccont rastdy e
 Ot her s: ant hr acy clines, dacar bazi ne, o Tacr olimus
pent ami di ne o Vancomy ci n
 

2

, Studytip:CrCl vsGFR Selectdrugst hatar eCII NKI DNEYI MPAI RMENT
o Cr Cl o Cr Cl <60
 Cockcr oft-Gaul tequat ion  Ni trof ur ant oin
140- pat i
enta g e o Cr Cl <50
 Cr Cl= ×we ightinkg
72xS Cr  El vitegr av ir/cobi cistat/
(×0.85i ff ema l
e ) emt ri
ci tabi ne/ TDF( Stribild)
 ForCr Cl cal culation, useABW i f  Vor iconazol eI V
pat i
enti s<I BW, useI BW isnor mal o Cr Cl <30
wei ght( byBMI )  Av anaf il
 Dosi ngadj ust ment sandCI ’
sar e  Bi sphosphonat es
gener allybasedonCr Cl calculated  Dabi gat ran
withCockcr oft-Gaul t  Dul oxet i
ne
o GFR  El vitegr av ir/cobi cistat/
 CKD- EPIorMDRDequat i
on emt ri
ci tabi ne/ TAF( Genv oy a)
 Usedf orst agingki dneydi sease  Fondapar inux
andf ordosi ngsel ectdr ugs  NSAI Ds
 Notcommonl ycal culat edint he  Pot assi um spar i
ngdi uretics
cli
ni cal setting, butmayber eported  Ri var oxaban
bysomel abor atories  Tadal af i
l
 Fort heexam, i
fGFRi snotpr ovided,  Tr amadol ER
CrCl pr ov i
desacl oseest i
mat ef or o GFR<30
doingandCIpur poses  Genv oy a
 Selectdrugst hatrequi r e OR I NTERVALWI TH  SGLT2i nhi bitors( canagl i
f l
ozin,
I
MPAI REDKI DNEYFUNCTI ON dapagl iflozi n,empagl if
lozi n)
o Ant i-i
nfectives  Met f ormi n
 Ami nogl ycosi des( dosi ngi nterval
, o Ot her s
primar ily)  Dof et il
ide
 Azt reonam  Edoxaban
 Bet a-lact ams  Gl ybur ide
 Pol ymy xins  Meper idine
 Qui nol ones( exceptmoxi f
loxacin)  Sot alol
 SMX- TMP  Keydr ugsthat KLEVELS
 Vancomy cin o ACEi
 Ant i-tuber cul osi smedi cations o ARBs
 Ant iviral s o Al dost eroner ecept orant agonists( ARAs)
 Amphot erici nB o Canagl iflozin
 Fl uconazol e o Dr ospi renone- cont ainingCOCs( combi ned)
 NRTI s, includi ngt enof ovir o Kcont ainingI VF( includi ngTPNs)
o CV o Ksuppl ement s
 Ant iar r
hy thmi cs( digoxi n, o SMX- TMP
disopy rami de, dof etil
ide, o Tacr ol i
mus
procai nami de, sot alol) o Ot her s:al i
ski ren, CYA, ev er
olimus,
 Dabi gat ran glycopy rrolat e, hepar in( chronicuse) ,NSAIDs,
 LMWHs pentami dine
 Ri var oxaban  Directacti
ngant ivir
als: pref er r
edHCVr egimens
 St at ins i
ncl ude2-3DAAswi thdi fferentMOAs( ofteni n1
o Pai n/gout tablet)
 Al lopur inol
Mechani
sm Namecl
ue
Exampl es
 Col chi cine
Grazopr evi
r
 Gabapent in, pregabal in -
prevai
r
NS3/4Apr otease Paritaprevi
r
 Mor phi neandcodei ne
i
nhibi
tors Simepr evir
 Tr amadol ER PforPI
Voxilaprevir
o GI
Daclatasv i
r
 Famot idine, r
ani ti
dine
-
asvir Ledipasv i
r
 Met ocl opr ami de NS5Ar epl
icati
on
Ombi t
asvir
o Ot her s complexinhibit
ors
Af
orNS5A Pibrentasvir
 Bi sphosphonat es
Velpatasv i
r
 CYA
 Li thium -buvir
NS5Bpol ymerase Dasabuv i
r
 Topi r amat e i
nhibi
tor Sofosbuv ir
Bf
orNS5B





3

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Studyabroad. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £5.54. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75632 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£5.54
  • (0)
  Add to cart